RHYTHM BIOSCIENCES LIMITED - Announcements

Market Cap $15.41M Add to my watchlist

Rhythm Biosciences Ltd is an Australia-based medical diagnostics company. The Company is... Rhythm Biosciences Ltd is an Australia-based medical diagnostics company. The Company is engaged in delivering simple, affordable blood tests for accurate and early detection of cancers. It is focused on improving patient outcomes through detection at the earliest possible stage, reducing the global burden of cancer and saving lives. The Company has developed ColoSTAT, a blood test for the detection of Colorectal Cancer (CRC). If diagnosed early, colorectal cancer is curable. The ColoSTAT Test-Kit measures five specific protein biomarkers that indicate the likelihood of CRC. The test is an alternative for individuals who are unable or unwilling to participate in current screening programs. It is being updated to meet the IVDR (In vitro diagnostic medical devices regulation) regulatory standards. It is focused on working with likeminded global partners to achieve commercialization and distribution of these simple solutions.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

RHY	Rhythm recruits first patient in ColoSTAT clinical trial	PRICE SENSITIVE	18/03/19		Share
RHY	Appendix 4D and Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/19		Share
RHY	RHY Signs first ColoSTAT site for Clinical Trial - Study 7	PRICE SENSITIVE	20/02/19		Share
RHY	Corporate Presentation	PRICE SENSITIVE	11/02/19		Share
RHY	Appendix 4C	PRICE SENSITIVE	29/01/19		Share
RHY	Rhythm Completes Reagent Development Program	PRICE SENSITIVE	05/12/18		Share
RHY	Appointment of CEO - Senior Management Changes	PRICE SENSITIVE	28/11/18		Share
RHY	AGM Presentation	PRICE SENSITIVE	26/11/18		Share
RHY	Appendix 4C	PRICE SENSITIVE	29/10/18		Share
RHY	Final Antibody Selection Complete	PRICE SENSITIVE	03/10/18		Share
RHY	Appendix 4E	PRICE SENSITIVE	31/08/18		Share
RHY	Appendix 4C	PRICE SENSITIVE	30/07/18		Share
RHY	Rhythm completes cloning of key reagent ahead of schedule	PRICE SENSITIVE	21/06/18	74.01KB	Share
RHY	Rhythm Granted Biomarker Patent in Europe	PRICE SENSITIVE	16/05/18		Share
RHY	RHY's Four Antibodies Pass all Three Key Screening Tests	PRICE SENSITIVE	14/05/18		Share
RHY	Appendix 4C	PRICE SENSITIVE	30/04/18		Share
RHY	Reagent Development Update	PRICE SENSITIVE	24/04/18		Share
RHY	Appendix 4D - Half Yearly Report	PRICE SENSITIVE	01/03/18		Share
RHY	Rhythm reports reagent development update	PRICE SENSITIVE	07/02/18		Share
RHY	Quarterly report and Appendix 4C	PRICE SENSITIVE	31/01/18		Share
RHY	CSIRO and Rhythm Commence Development of Key Reagents	PRICE SENSITIVE	24/01/18		Share
RHY	CSIRO to assist Rhythm Biosciences develop key reagents	PRICE SENSITIVE	09/01/18		Share
RHY	Admission to Official List	PRICE SENSITIVE	06/12/17		Share

RHY Rhythm recruits first patient in ColoSTAT clinical trial
18/03/19	PRICE SENSITIVE		Share
RHY Appendix 4D and Half Yearly Report and Accounts
26/02/19	PRICE SENSITIVE		Share
RHY RHY Signs first ColoSTAT site for Clinical Trial - Study 7
20/02/19	PRICE SENSITIVE		Share
RHY Corporate Presentation
11/02/19	PRICE SENSITIVE		Share
RHY Appendix 4C
29/01/19	PRICE SENSITIVE		Share
RHY Rhythm Completes Reagent Development Program
05/12/18	PRICE SENSITIVE		Share
RHY Appointment of CEO - Senior Management Changes
28/11/18	PRICE SENSITIVE		Share
RHY AGM Presentation
26/11/18	PRICE SENSITIVE		Share
RHY Appendix 4C
29/10/18	PRICE SENSITIVE		Share
RHY Final Antibody Selection Complete
03/10/18	PRICE SENSITIVE		Share
RHY Appendix 4E
31/08/18	PRICE SENSITIVE		Share
RHY Appendix 4C
30/07/18	PRICE SENSITIVE		Share
RHY Rhythm completes cloning of key reagent ahead of schedule
21/06/18	PRICE SENSITIVE	74.01KB	Share
RHY Rhythm Granted Biomarker Patent in Europe
16/05/18	PRICE SENSITIVE		Share
RHY RHY's Four Antibodies Pass all Three Key Screening Tests
14/05/18	PRICE SENSITIVE		Share
RHY Appendix 4C
30/04/18	PRICE SENSITIVE		Share
RHY Reagent Development Update
24/04/18	PRICE SENSITIVE		Share
RHY Appendix 4D - Half Yearly Report
01/03/18	PRICE SENSITIVE		Share
RHY Rhythm reports reagent development update
07/02/18	PRICE SENSITIVE		Share
RHY Quarterly report and Appendix 4C
31/01/18	PRICE SENSITIVE		Share
RHY CSIRO and Rhythm Commence Development of Key Reagents
24/01/18	PRICE SENSITIVE		Share
RHY CSIRO to assist Rhythm Biosciences develop key reagents
09/01/18	PRICE SENSITIVE		Share
RHY Admission to Official List
06/12/17	PRICE SENSITIVE		Share

REFRESH

(20min delay)
Last 9.3¢		Change 0.002(1.65%)		Mkt cap ! $15.41M

Open	High	Low	Value	Volume
9.0¢	9.4¢	9.0¢	$71.56K	768.2K

Buyers (Bids)

No.	Vol.	Price($)
3	157347	9.2¢

Sellers (Offers)

Price($)	Vol.	No.
9.3¢	21660	2

View Market Depth

No.	Vol.	Price($)
2	75525	0.063
1	16000	0.062
2	83639	0.060
2	38605	0.051
1	66665	0.045

Price($)	Vol.	No.
0.064	9245	1
0.065	51999	3
0.066	107305	1
0.067	195346	2
0.070	1794	1

Last trade - 12.33pm 29/11/2024 (20 minute delay)


Last 9.3¢		Change 0.002 ( 1.09 %)
Open	High	Low	Volume
9.3¢	9.4¢	9.3¢	274057
Last updated 12.07pm 29/11/2024 ?

RHY (ASX) Chart